Simulands: Practice makes perfect as Zurich's Simulands receives 10 million

Simulands, a Swiss creator of simulation devices for cardiovascular medicine, recently obtained €10 million to give cardiologists sound training that's appropriate for the mission-critical nature of their field. The funding is being supplied by healthcare private equity firm SHS, investing from its recently launched sixth fund vintage to accelerate Simulands' commercialisation plans for its cardiac intervention training equipment. Simulands' portable device replicates pathological anatomy - parts of the cardiovascular system prone to disease - using novel materials and additive manufacturing to mirror real-world patient scenarios. A safe training environment is absolutely vital to reduce stress for trainee physicians. Andrea Guidotti, Simulands CEO, added: "Technological and scientific innovations are advancing the practice of medicine and augmenting physicians' capabilities.